Immunic
IMUX

Immunic (IMUX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$22.00Sep 10, 2026
WedbushMaintainedOutperform$45.00Sep 10, 2026
WedbushInitiated CoverageOutperform$45.00Aug 17, 2026
B. Riley SecuritiesMaintainedBuy$27.00 from $40.00May 22, 2026
HC Wainwright & Co.MaintainedBuy$22.00 from $5.00Apr 30, 2026
StifelInitiated CoverageBuy$2.50Apr 17, 2026
D. Boral CapitalDowngradedBuy → Hold—Apr 15, 2026
GuggenheimInitiated CoverageBuy$7.00Mar 24, 2026
HC Wainwright & Co.MaintainedBuy$5.00 from $8.00Mar 2, 2026
D. Boral CapitalMaintainedBuy$4.00 from $8.00Feb 13, 2026
HC Wainwright & Co.MaintainedBuy$8.00Feb 9, 2026
D. Boral CapitalMaintainedBuy$8.00Jan 7, 2026
HC Wainwright & Co.MaintainedBuy$8.00 from $10.00Nov 14, 2025
D. Boral CapitalMaintainedBuy$8.00 from $10.00Nov 13, 2025
Chardan CapitalInitiated CoverageBuy$3.00Sep 29, 2025
HC Wainwright & Co.MaintainedBuy$10.00Sep 26, 2025
D. Boral CapitalMaintainedBuy$10.00Sep 25, 2025
D. Boral CapitalMaintainedBuy$10.00Aug 8, 2025
D. Boral CapitalMaintainedBuy$10.00Jun 25, 2025
D. Boral CapitalMaintainedBuy$10.00Jun 5, 2025

Frequently asked questions

  • What is the latest analyst rating on IMUX?

    On Sep 10, 2026, HC Wainwright & Co. maintained Immunic at Buy with a price target of $22.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.